0001127602-24-018703.txt : 20240614
0001127602-24-018703.hdr.sgml : 20240614
20240614161808
ACCESSION NUMBER: 0001127602-24-018703
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POTTER MYRTLE S
CENTRAL INDEX KEY: 0001214130
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40097
FILM NUMBER: 241045076
MAIL ADDRESS:
STREET 1: 10 FINDERNE AVE
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc.
CENTRAL INDEX KEY: 0001830214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 872652913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (877) 442-5362
MAIL ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20210210
FORMER COMPANY:
FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20201027
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-06-13
0001830214
Ginkgo Bioworks Holdings, Inc.
DNA
0001214130
POTTER MYRTLE S
C/O GINKGO BIOWORKS HOLDINGS, INC.
27 DRYDOCK AVENUE
BOSTON
MA
02210
1
0
Stock Option
.462
2024-06-13
4
A
0
1111111
0
A
2034-06-13
Class A Common Stock
1111111
1111111
D
Stock Option
.462
2024-06-13
4
A
0
571428
0
A
2034-06-13
Class A Common Stock
571428
571428
D
Restricted Stock Units
0
2024-06-13
4
A
0
432900
0
A
Class A Common Stock
432900
432900
D
In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the initial option award as of the grant date is $400,000.
The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the additional initial option award as of the grant date is $200,000.
The vesting date of the RSUs and additional initial options, and in the case of the additional initial options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
/s/ Karen Tepichin, Attorney-in-Fact
2024-06-14